See more : CSPC Pharmaceutical Group Limited (1093.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Indiva Limited (NDVAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Indiva Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Coherent, Inc. (0LHO.L) Income Statement Analysis – Financial Results
- Chimera Investment Corporation (CIM-PB) Income Statement Analysis – Financial Results
- Sodick Co., Ltd. (6143.T) Income Statement Analysis – Financial Results
- Cicero Inc. (CICN) Income Statement Analysis – Financial Results
- Kimberly-Clark Corporation (0JQZ.L) Income Statement Analysis – Financial Results
Indiva Limited (NDVAF)
About Indiva Limited
Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA and Artisan Batch brands, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Slow Ride Bakery Cookies, Jewels Chewable Tablets, Ruby Cannabis Sugar, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37.57M | 34.40M | 32.47M | 14.65M | 923.86K | 58.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23.35K | 29.13K | 17.41K | 38.32K | 69.96K | 121.59K | 65.59K |
| Cost of Revenue | 27.05M | 26.25M | 25.40M | 15.52M | 869.50K | 43.14K | 188.37K | 1.16K | 4.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.82K | 17.96K | 6.29K | 25.29K | 52.57K | 70.58K | 48.65K |
| Gross Profit | 10.52M | 8.15M | 7.07M | -873.55K | 54.36K | 15.16K | -188.37K | -1.16K | -4.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.53K | 11.17K | 11.12K | 13.03K | 17.39K | 51.01K | 16.94K |
| Gross Profit Ratio | 28.00% | 23.70% | 21.76% | -5.96% | 5.88% | 26.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 32.26% | 38.35% | 63.89% | 34.01% | 24.86% | 41.95% | 25.82% |
| Research & Development | 877.01K | 1.02M | 416.96K | 11.64K | 122.59K | 24.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.01M | 6.29M | 6.56M | 5.86M | 6.92M | 6.74M | 2.06M | 889.99K | 219.93K | 918.44K | 83.36K | 81.67K | 110.20K | 205.35K | 116.63K | 178.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 5.35M | 6.53M | 4.94M | 1.61M | 2.16M | 605.46K | 364.92K | 222.57K | 34.97K | 57.25K | 0.00 | 1.02K | 848.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.37M | 12.82M | 11.50M | 7.47M | 9.08M | 7.35M | 2.42M | 1.11M | 254.90K | 975.69K | 83.36K | 82.69K | 111.04K | 205.35K | 116.63K | 178.84K | 379.13K | 356.69K | 168.15K | 334.90K | 165.46K | 167.19K | 178.89K |
| Other Expenses | 402.92K | 413.50K | 1.59M | 3.18M | 953.44K | 0.00 | -2.33K | -8.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.42K | 0.00 | -846.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 12.65M | 14.25M | 13.51M | 10.66M | 10.15M | 7.75M | 2.76M | 1.14M | 258.91K | 976.59K | 83.36K | 82.69K | 111.04K | 205.35K | 116.76K | 179.08K | 386.42K | 361.96K | 175.49K | 345.38K | 176.72K | 172.80K | 180.65K |
| Cost & Expenses | 39.70M | 40.50M | 38.91M | 26.18M | 11.02M | 7.71M | 2.76M | 1.14M | 258.91K | 976.59K | 83.36K | 82.69K | 111.04K | 205.35K | 116.76K | 179.08K | 402.24K | 379.92K | 181.78K | 370.67K | 229.29K | 243.38K | 229.30K |
| Interest Income | 0.00 | 36.13K | 217.69K | 7.00 | 137.33K | 112.88K | 29.65K | 0.00 | 0.00 | 1.57K | 0.00 | 0.00 | 1.27K | 44.00 | 92.00 | 5.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.91M | 4.45M | 2.93M | 2.02M | 439.54K | 1.16M | 248.65K | 0.00 | 0.00 | 14.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 45.24K | 0.00 | 26.55K | 28.22K | 64.34K | 42.95K | 677.00 | 5.86K |
| Depreciation & Amortization | 393.33K | 410.48K | 484.93K | 386.93K | 862.85K | 407.09K | 188.37K | 29.84K | 4.01K | 906.00 | -166.72K | -165.37K | -222.09K | -378.92K | 126.00 | 240.00 | 7.29K | 5.27K | 7.34K | 10.49K | 11.27K | 5.61K | 1.76K |
| EBITDA | 272.34K | -5.89M | -11.04M | -11.03M | -10.10M | -7.13M | -948.25K | -1.10M | -235.46K | -974.12K | -83.36K | -82.69K | -111.04K | 1.03M | 453.30K | 1.78M | -371.60K | -345.52K | -157.03K | -321.87K | -148.07K | -116.19K | -161.95K |
| EBITDA Ratio | 0.72% | -17.13% | -34.00% | -75.27% | -1,027.15% | -12,230.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,591.41% | -1,186.15% | -902.10% | -840.03% | -211.65% | -95.56% | -246.91% |
| Operating Income | -2.13M | -6.10M | -6.44M | -8.74M | -10.10M | -7.54M | -1.14M | -1.13M | 258.91K | 971.22K | 83.36K | 82.69K | 111.04K | 1.41M | 686.69K | 2.18M | -378.89K | 350.79K | 164.37K | 332.35K | 159.33K | 121.80K | 163.71K |
| Operating Income Ratio | -5.66% | -17.73% | -19.84% | -59.68% | -1,092.91% | -12,928.20% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,622.64% | 1,204.26% | 944.28% | 867.40% | 227.75% | 100.18% | 249.59% |
| Total Other Income/Expenses | -2.79M | -4.95M | -9.94M | -6.54M | -1.30M | -1.01M | -475.68K | -59.36K | -11.49K | -2.12M | -166.72K | -165.37K | -220.82K | -1.23M | -569.93K | -2.81M | 0.00 | -350.79K | -164.37K | -332.35K | -159.33K | -121.80K | -163.71K |
| Income Before Tax | -4.92M | -11.05M | -15.28M | -15.42M | -11.40M | -8.66M | -4.60M | -1.17M | -767.60K | -1.15M | -83.36K | -82.69K | -109.78K | 178.00K | 116.76K | -622.24K | 0.00 | 0.00 | 0.00 | 0.00 | 191.35K | 147.83K | 0.00 |
| Income Before Tax Ratio | -13.09% | -32.12% | -47.05% | -105.26% | -1,233.72% | -14,845.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 273.51% | 121.58% | 0.00% |
| Income Tax Expense | 0.00 | -118.30K | -266.95K | 1.06K | 46.87K | -129.46K | -47.96K | 20.93K | 508.69K | 14.00K | 0.00 | 0.00 | 220.82K | 1.61M | 570.29K | 2.02M | 40.15K | 26.55K | 28.22K | 64.34K | 42.95K | 677.00 | 5.86K |
| Net Income | -4.92M | -10.93M | -15.01M | -15.42M | -11.44M | -8.53M | -4.55M | -1.17M | -767.60K | -1.15M | -83.36K | -82.69K | -109.78K | -1.43M | -687.05K | -3.04M | -419.03K | -377.34K | -192.59K | -396.70K | -170.27K | -96.45K | -169.57K |
| Net Income Ratio | -13.09% | -31.78% | -46.22% | -105.27% | -1,238.80% | -14,623.68% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,794.57% | -1,295.41% | -1,106.39% | -1,035.33% | -243.37% | -79.33% | -258.53% |
| EPS | -0.03 | -0.08 | -0.11 | -0.16 | -0.14 | -0.11 | -0.12 | -0.05 | -2.72 | -4.97 | -0.86 | -1.13 | -1.58 | -37.85 | -30.97 | -155.52 | -22.88 | -34.33 | -20.84 | -60.99 | -26.18 | -14.83 | -26.07 |
| EPS Diluted | -0.03 | -0.08 | -0.11 | -0.16 | -0.14 | -0.11 | -0.12 | -0.05 | -2.72 | -4.97 | -0.86 | -1.13 | -1.58 | -37.85 | -30.97 | -155.52 | -22.88 | -34.33 | -20.84 | -60.99 | -26.18 | -14.83 | -26.07 |
| Weighted Avg Shares Out | 168.92M | 134.91M | 134.48M | 95.62M | 83.16M | 79.55M | 37.28M | 21.44M | 282.30K | 230.90K | 97.45K | 72.94K | 69.34K | 37.86K | 22.19K | 19.58K | 18.31K | 10.99K | 9.24K | 6.50K | 6.50K | 6.50K | 6.50K |
| Weighted Avg Shares Out (Dil) | 168.92M | 134.91M | 134.48M | 95.62M | 83.16M | 79.55M | 38.44M | 21.44M | 282.30K | 230.90K | 97.45K | 72.94K | 69.34K | 37.86K | 22.19K | 19.58K | 18.31K | 10.99K | 9.24K | 6.50K | 6.50K | 6.50K | 6.50K |
Indiva Limited (NDVAF) Q1 2024 Earnings Call Transcript
Indiva Limited (OTCPK:NDVAF) Q1 2024 Results Conference Call May 23, 2024 10:30 AM ET Company Participants Neil Marotta - CEO Jennifer Welsh - CFO Operator Good morning, ladies and gentlemen, and welcome to the Indiva Limited Q1 2024 Earnings Conference...
Indiva Provides Corporate Update Including Improved Fourth Quarter Revenue Guidance
LONDON, Ontario--(BUSINESS WIRE)--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to provide a corporate update and recap of fiscal 2023, including improved quarterly guidance, as the Company now expects record net revenue...
Indiva Limited (NDVAF) Q3 2023 Earnings Call Transcript
Indiva Limited (OTCPK:NDVAF) Q3 2023 Earnings Conference Call November 21, 2023 10:30 AM ET Company Participants Niel Marotta - CEO Jennifer Welsh - CFO Conference Call Participants Andrew Semple - Echelon Capital Markets Operator Good morning, ladies and gentlemen, and...
Indiva to Report Third Quarter Results Pre-Market on Tuesday, November 21, 2023
LONDON, Ontario--(BUSINESS WIRE)--Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, will report its results for the three and nine months ended September 30, 2023 pre-market on Tuesday, November 21, 2023....
Indiva Limited (NDVAF) Q2 2023 Earnings Call Transcript
Indiva Limited (OTCPK:NDVAF) Q2 2023 Earnings Conference Call August 29, 2023 10:30 AM ET Company Participants Niel Marotta - Chief Executive Officer Jennifer Welsh - Chief Financial Officer Conference Call Participants Andrew Semple - Echelon Capital Markets Operator Good morning,...
Indiva to Report Second Quarter Results Pre-Market on Tuesday, August 29, 2023
LONDON, Ontario--(BUSINESS WIRE)--Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, will report its results for the three and six months ended June 30, 2023 pre-market on Tuesday, August 29, 2023....
Indiva Limited (NDVAF) Q4 2022 Earnings Call Transcript
Indiva Limited (NDVAF) Q4 2022 Earnings Call Transcript
Indiva to Report Fourth Quarter and Full Year Results Pre-Market on Tuesday April 18, 2023
LONDON, Ontario--(BUSINESS WIRE)--Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA), the leading Canadian producer of cannabis edibles and other cannabis products, will report its results for the year ended December 31, 2022 pre-market on Tuesday, April 18, 2023. CONFERENCE CALL -...
Indiva Limited (NDVAF) Q3 2022 Earnings Call Transcript
Indiva Limited (OTCQX:NDVAF) Q3 2022 Earnings Conference Call November 22, 2022 8:30 AM ET Company Participants Niel Marotta - President, Chief Executive Officer and Co-Founder Jennifer Welsh - Chief Financial Officer Conference Call Participants Eric Livshits - ATB Capital Markets...
Indiva Limited (NDVAF) CEO Niel Marotta on Q2 2022 Results - Earnings Call Transcript
Indiva Limited (OTCQX:NDVAF) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Niel Marotta - CEO Jennifer Welsh - CFO Conference Call Participants Andrew Semple - Echelon Capital Markets Operator Good morning ladies and gentlemen and...
Source: https://incomestatements.info
Category: Stock Reports